Selleck Chemicals - Model A2475 -Glembatumumab (Anti-GPNMB)

Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.